Human immunodeficiency virus type 1 (HIV-1)-mediated syncytium formation is recognized as being highly dependent on intercellular adhesion molecule (ICAM)-1-leukocyte function-associated molecule 1 (LFA)-1 interaction, whereas the process of infection with cell-free virions is independent of such complementary interaction. Our group has recently demonstrated that an antibody-mediated induction of the high affinity state of LFA-1 for ICAM-1 renders target T cells more prone to HIV-1-dependent syncytium formation and infection by ICAM-1-bearing virions. To further substantiate these results, we made use of mutant cell lines expressing LFA-1 in either a low (parental HPB-ALL and HAmut) or a high affinity state for ICAM-1 (HAP4) and compared syncytium formation and virus infection. Cells expressing the activated form of LFA-1 were found to be more susceptible to HIV-1-induced syncytium formation and to infection by ICAM-1-bearing HIV-1 particles. The observed increase was solely due to the LFA-1 activation state because it was abrogated by anti-LFA-1 or anti-ICAM-1 antibodies and not due to variations in surface expression of LFA-1, CD4, or the chemokine coreceptor CXCR4. However, a linear relation was seen between the level of CXCR4 surface expression and susceptibility to syncytium formation/virus infection when ICAM-1-LFA-1 interaction was either absent (i.e., infection with ICAM-1-negative virions) or abrogated (treatment with anti-LFA-1 or anti-ICAM-1 antibodies). These results emphasize the important role of the LFA-1 activation state with respect to virus-induced syncytium formation and HIV-1 infection.
INTRODUCTION
For many years, the fine details of the process of attachment and entry of the human immunodeficiency virus type-1 (HIV-1) have remained elusive. Shortly after the isolation of the HIV-1 virus, it was quickly demonstrated that an interaction of the gp120 viral envelope protein with the cell surface CD4 molecule was necessary for viral entry but not sufficient (Dalgleish et al., 1984; Klatzmann et al., 1984; Maddon et al., 1986) . It has taken more than a decade to identify the first of a long list of coreceptors used by HIV-1 to enter target cells (Feng et al., 1996; Moore, 1997) . These coreceptors are members of the seven-transmembrane chemokine receptor family, with CCR5 being the most widely used by macrophage-tropic strains and CXCR4 being the sole receptor used by T-tropic strains of HIV-1 (reviewed in Clapham and Weiss, 1997) . The discovery of these coreceptors along with successful crystallizations of a fragment of the ectodomain of gp41 (Weissenhorn et al., 1997) , and, more recently, the crystallization of the gp120 (Kwong et al., 1998) have helped to unravel the mechanism of HIV-1 entry. It is now thought that after the high affinity attachment of gp120 to the cell surface CD4 glycoprotein, gp120 undergoes several conformational changes, thereby resulting in the creation of a high affinity binding site for the appropriate coreceptor. The interaction between the coreceptor and the CD4-gp120 complex then destabilizes the gp120 trimers, leading to the uncovering of the transmembrane viral gp41 fusion peptide. The culmination of this series of events is the merging of the viral and cellular membranes and the entry of the viral nucleocapsid into the cytoplasm of the target cell (Binley and Moore, 1997) .
Like for other retroviruses, the egress of HIV-1 is taking place at the cytoplasmic membrane. Numerous studies have shown that in addition to the viral gp120-gp41 molecules found on the virion's surface, newly formed viral entities incorporate a vast array of host-derived proteins. The long list of host cell membrane molecules acquired by HIV-1 includes the determinants of the major histocompatibility complex class I and II (MHC-I, -II) adhesion molecules such as CD44, ICAM-1, leukocyte function-associated molecule 1 (LFA-1), and complement control proteins such as CD55 and CD59 (reviewed in Tremblay et al., 1998) . In the past few years, the study of HIV-1-incorporated host molecules has been a very ac-tive field of research; consequently, it is now well documented that these host constituents are affecting the viral life cycle in many different ways (reviewed in Tremblay et al., 1998) . One of the best characterized mode by which virally embedded host molecules affect the biology of HIV-1 is through an increase in viral infectivity.
ICAM-1 is a member of the immunoglobulin (Ig) superfamily and is constituted of five Ig-like domains. ICAM-1 is primarily expressed on lymphocytes, monocytes/macrophages, granulocytes, and certain epithelial cells, and its expression can be strongly up-regulated by several agents (Springer, 1990) . The counterligand for ICAM-1 is LFA-1, a member of the integrin family. In contrast to ICAM-1, LFA-1 expression is restricted to hematopoietic cells, being expressed exclusively on lymphocytes, granulocytes, and monocytes/macrophages (Springer, 1990) .
Cells productively infected with HIV-1 express on their surface the viral gp120 and gp41 proteins. Interaction between these viral proteins and the CD4-chemokine coreceptor complex on the surface of an uninfected target cell can lead to cell-cell fusion (also termed syncytium formation), which represents the best characterized type of HIV-1-induced cell death (Dragic et al., 1996; Feng et al., 1996; Lifson et al., 1986a Lifson et al., , 1986b . Beside these primordial interactions, the ICAM-1-LFA-1 interaction has been shown to be important and, in fact, almost essential in syncytium formation. This is particularly true when the level of gp120 is too low to provide a binding strength sufficient to overcome the overall negative electrostatic repulsion forces between HIV-1-infected cells and uninfected CD4 ϩ target cells (Gruber et al., 1991; Pantaleo et al., 1991) . This LFA-1 dependency for virusmediated syncytium formation does not seem to be essential for HIV-1 entry, although we and others have demonstrated that virion-bound ICAM-1 proteins are still functional and that their physical presence results in a marked enhancement of HIV-1 infectivity (5-to 10-fold increase) Paquette et al., 1998; Rizzuto and Sodroski, 1997) . It should be stated that LFA-1 can be found in two distinct conformational states, under either a low or a high affinity state for ICAM-1. The activation of leukocytes either through the addition of phorbol esters or chemoattractants or through crosslinking of specific surface receptors such as the T cell receptor (TCR)-CD3 complex, CD2, and MHC-II induces an LFA-1-mediated binding to ICAM-1, which is thought to largely depend on a change in LFA-1 conformational state (Diamond and Springer, 1994) . Interestingly, results from studies into which the conformational state of LFA-1 was modified by an anti-LFA-1 antibody (clone NKI-L16) revealed that LFA-1 activation on the surface of target cells results in an increased cellular susceptibility to infection by ICAM-1-bearing progeny viruses and to an enhancement of HIV-1-induced syncytium formation (Barbeau et al., 1998; Fortin et al., 1998) .
Given that modification of the conformational state of LFA-1 was mediated in such studies by antibodies, we wondered whether similar observations could be made when using cell lines constitutively expressing LFA-1 with either a low or a high affinity state for ICAM-1. Our results indicate that HIV-1-induced cytopathology (i.e., syncytium formation) and susceptibility to infection with ICAM-1-bearing HIV-1 particles are still potentiated in HPB-ALL-derived T lymphoid cell lines expressing LFA-1 in a conformational state of high affinity for ICAM-1.
RESULTS

Analysis of LFA-1 expression on HBP-ALL and its derivatives
The primary objective of the present study was to analyze the effect of the conformational state of LFA-1 with respect to HIV-1-dependent cell-cell fusion and the early events of the process of virus infection. This goal was achieved using the parental human T cell leukemic cell line HPB-ALL and two of its derivatives, HAmut and HAP4. Originally, HAmut and HAP4 cells were derived by mutagenesis from the parental HPB-ALL cell line to study the molecular mechanisms regulating ␤ 2 -integrin adhesiveness (Hedman et al., 1997) . HAmut represents the heterologous population obtained immediately after mutagenesis of HPB-ALL cells with the mutagenic agent ethyl methanesulfonate. This HAmut mixed population was next used as a starting material to select clonal populations of cells expressing on their surface a constitutively active form of LFA-1. HAP4 is such a clonal population, which was obtained after six rounds of selection with magnetic beads coated with an ICAM-1 fusion protein.
We first monitored the expression of both chains of LFA-1 (␣ and ␤) on the surface of the studied cell lines (i.e., HPB-ALL, HAmut, and HAP4) by indirect immunofluorescence staining. As depicted in Fig. 1 , all three cell lines express similar levels of both LFA-1 chains. Despite comparable levels of surface LFA-1, HAP4 cells are characterized by a more pronounced ICAM-1-binding phenotype, which is due to the expression of a constitutively activated form of LFA-1 (Hedman et al., 1997) . This remarkable property of HAP4 was confirmed by flow cytometric analysis with mAb24, an anti-LFA-1 monoclonal antibody known to be specific for an epitope exclusively expressed on activated LFA-1 (Landis et al., 1993) . From Fig. 1 , it can be seen that almost 45% of HAP4 cells are expressing the LFA-1 activation epitope compared with 0.4% and 7% for HPB-ALL and HAmut cells, respectively. The parental HPB-ALL cell line and its derivatives represent an ideal tool for our studies because they do not require any treatment to induce the conformational change of LFA-1. Therefore, it is an appropriate system to simultaneously study the effect of the activation state of LFA-1 on HIV-1-mediated syncytium formation and infection by ICAM-1-bearing HIV-1 virions.
Expression of the LFA-1-activated form on the surface of HAP4 cells is correlated with an increased susceptibility to HIV-1-mediated syncytium formation
The parental HBP-ALL cell line and its derivatives, HAmut and HAP4, were used in a visual syncytium assay. These cells were mixed at a 2:1 ratio with the chronically HIV-1-infected cell line J1.1 for 6 h, and the syncytium number was determined from each cell mixture. With the HPB-ALL cell line, low levels of syncytia were observed after incubation with J1.1 cells (Fig. 2) . The HAmut population showed a slight increase in cellular aggregation along with an increase in HIV-1-dependent syncytium number. Finally, in parallel with their higher level of cellular aggregation, the HAP4 cells were much more prone to virus-mediated syncytium formation. In fact, not only were the syncytia formed by these cells more abundant but also they were much bigger. As a control, incubation of J1.1 cells alone showed no syncytium formation, which is due to the absence of CD4 expression resulting from chronic HIV-1 infection. These results are thus in agreement with our previous work indicating that antibody-induced LFA-1 activation can positively affect HIV-1-mediated syncytium formation (Barbeau et al., 1998) .
Because HAmut and HAP4 cells have been obtained from chemically mutagenized cells, there remains the possibility that the observed enhancement of syncytium formation could be due to cellular modifications other than the selected ICAM-1-binding phenotype. To confirm the specificity of the observation, cell mixtures were next performed in the presence of anti-LFA-1 and anti-ICAM-1 antibodies recognized to block the ICAM-1-LFA-1 interaction. On the addition of the anti-ICAM-1 RR1/1.1.1 antibody, the low levels of syncytia formed with HPB-ALL and HAmut cells were modestly affected ( Fig. 3A ). However, cellular aggregation and HIV-1-mediated syncytium formation were both strongly reduced when the HAP4/J1.1 mixture was treated with the anti-ICAM-1 antibody (compare RR1/1.1.1 with untreated). Cells treated with SIM.4, an anti-CD4 antibody known to block syncytium formation (McCallus et al., 1992) , were used as positive controls. As expected, this treatment resulted in an almost complete inhibition of virus-induced syncytium formation with all cell lines tested without inhibiting cellular aggregation. Enumeration of syncytia visualized by microscopy is presented in Fig. 3B . These data indicate that ϳ40 syncytia/field are counted when HPB-ALL and HAmut are mixed together with J1.1 cells. More than 90 syncytia/ field were visualized when J1.1 cells were coincubated with HAP4. Comparable numbers of syncytia were counted on treatment of all three cell lines with the anti-ICAM-1 RR1/1.1.1 antibody (ϳ20 syncytia/ field). Finally, Ͻ10 syncytia/ field were detected with SIM.4 treat-FIG. 1. Analysis of LFA-1 expression on HPB-ALL and its HAmut and HAP4 derivatives. Cells were incubated with an antibody specific for the ␣ chain (CD11a) (clone TS1/22.1), ␤ chain (CD18) (clone TS1/18.1), or an activation epitope (clone mAb24) of LFA-1 in combination with a (R)phycoerythrin-conjugated goat anti-mouse IgG (dotted lines). Controls consisted of cells incubated with an isotype-matched irrelevant monoclonal antibody (solid lines). ment of cocultured J1.1 cells with HPB-ALL, HAmut, and HAP4 cells. In a different experimental settings, cells were also treated with the anti-LFA-1 TS1/22.1-blocking antibody. This treatment resulted in a general decrease in cellular aggregation and HIV-1-mediated syncytium formation, with a more pronounced effect with the HAP4/ J1.1 cell mixture (compare TS1/22.1 with untreated) (Fig.  4A ). Quantitative measurements revealed that the coculture of J1.1 cells with HBP-ALL, HAmut, and HAP4 resulted in the generation of 20, 23, and 63 syncytia/ field, respectively. The addition of TS1/22.1 to the cell mixture resulted in a slight diminution of the number of syncytia with the HAmut cell line (23 versus 18) and a more pronounced decrease with the HAP4 cell line (63 versus 18) ( Fig. 4B ).
Susceptibility to infection by ICAM-1-bearing particles is also increased for HAP4 cells
We next examined whether the early events in the viral infectious cycle could be similarly up-regulated in cells constitutively expressing an activated LFA-1 in a conformational state of high affinity for ICAM-1 (i.e., HAP4 cells). To achieve such a goal, we made use of recombinant luciferase-encoding HIV-1 particles bearing or not bearing host-encoded ICAM-1 proteins on their surfaces (ICAM-1/POS and ICAM-1/NEG virus stocks). Previous observations indicated that this system represents a highly sensitive and reproducible assay to monitor single-cycle viral infection events Paquette et al., 1998) . Our working hypothesis was that the presence of host-derived ICAM-1 in the viral envelope would increase virus infectivity in HAP4 cells, much like the process of virus-mediated syncytium formation. No significant differences were noticed when HPB-ALL and mutated derivatives were infected with identical amounts of ICAM-1/NEG progeny virions (Fig. 5) . The small differences that were observed between the three cell lines studied could probably be explained by variations in the levels of expression of the viral chemokine coreceptor CXCR4 (see below). However, we observed that ICAM-1/POS virions were 1.5-fold more infectious than ICAM-1/NEG progeny viruses in HPB-ALL and HAmut cell lines. Interestingly, a fourfold increase in virus made for cells pretreated with the blocking anti-LFA-1 TS1/22.1 antibody (data not shown). These results thus indicate that the enhancement of virus infectivity seen in LFA-1-positive cells in respect to its affinity state is strictly due to interaction between virally acquired host ICAM-1 and its physiological LFA-1 counterreceptor expressed on the target cell. Altogether, our findings indicate that the processes of syncytium formation and entry mediated by HIV-1 thus are modulated not only by the primary cellular receptor (i.e., CD4) and the appropriate chemokine coreceptor (in this case, CXCR4) but also by the conformational state of LFA-1.
Direct linear correlation between the level of CXCR4 expression and HIV-1-dependent syncytium formation/viral infection processes when ICAM-1-LFA-1 interaction was absent
It is clear from data shown in Figs. 3-5 that when the interaction between ICAM-1 and LFA-1 was absent, variations were observed among the three cell lines used with respect to syncytium formation and virus infectivity. Given that expression of surface CD4 was previously reported to be similar for the three cell lines tested (Hedman and Lundgren, 1996) , a finding that we were able to corroborate (data not shown), the chemokine coreceptor seems the most logical limiting factor that could account for such differences. Flow cytometric analyses were then performed on the three cell lines to evaluate the level of CXCR4 surface expression, the chemokine coreceptor necessary to allow infection with T cell tropic strains of HIV-1 (Feng et al., 1996) . A comparison of the levels of CXCR4, as reflected by the mean fluorescence intensity (indicative of the number of molecules per single cell shown on a logarithmic scale), showed that surface expression was the highest on HAmut (MFI ϭ 4.5), moderate on HPB-ALL (MFI ϭ 3.0), and lowest on HAP4 (MFI ϭ 2.1) (Fig. 6) . By plotting the number of syncytia and the amounts of virus-mediated luciferase activity against the surface expression levels of CXCR4 for the different cell lines in conditions where ICAM-1-LFA-1 interaction is abrogated or absent, significant linear correlations were obtained between syncytium formation/virus infection and the levels of CXCR4 (Fig. 7) . These data demonstrate that in the absence of ICAM-1-LFA-1 interaction, the level of surface expression of CXCR4 affects HIV-1 infectivity and virus-mediated syncytium formation.
DISCUSSION
The ICAM-1-LFA-1 interaction has been previously shown to be of prime importance for HIV-1-dependent syncytium formation and to be dispensable for the process of infection with cell-free virus. However, it has been recently reported that the ICAM-1-LFA-1 association can also positively modulate virus infection under some specific circumstances. Indeed, target cells expressing LFA-1 in a conformational state of high affinity for ICAM-1 have been reported to be more prone to infection with virions bearing on their surface host-derived ICAM-1 proteins . The present study was undertaken to further study the precise role played by the ICAM-1-LFA-1 interaction in both HIV-1mediated syncytium formation and virus infection. Such a goal was accomplished with the use of HPB-ALL cells and mutant cells constitutively expressing an active ␤ 2integrin LFA-1, which permitted us to substantiate earlier studies in a different cell setting (Hedman et al., 1997) . Our findings indicate that HAP4, a subclone of HPB-ALL cells that expresses an activated form of LFA-1 on its surface, is more susceptible to both virus-dependent syncytium formation and infection with progeny viruses bearing host-encoded ICAM-1 on their outer membranes.
Flow cytometric analyses were initially performed to determine that the observed variations in terms of susceptibility to cell-cell fusion and virus infection between the three different cell lines studied were due only to the FIG. 5. HAP4 cells are more susceptible to infection by ICAM-1bearing HIV-1 particles. Virus stocks were treated or not treated for 30 min at 37°C with the anti-ICAM-1 RR1/1.1.1 antibody before incubation with HPB-ALL, HAmut, and HAP4 cells. Cells were next lysed at 72 h postinfection, and luciferase activity was monitored as described in Materials and Methods. Results represent the mean Ϯ S.D. of triplicate samples.
FIG. 6. The chemokine coreceptor CXCR4 is differently expressed on HPB-ALL, HAmut, and HAP4 cells. Cells were stained with the 12G5 antibody followed by a (R)-phycoerythrin-conjugated goat anti-mouse IgG (dotted lines). Controls consisted of cells incubated with an isotype-matched irrelevant monoclonal antibody (solid lines). difference in the active state of the ␤ 2 -integrin LFA-1. These studies were prompted by previous data indicating that although HAmut expressed detectable levels of integrin ␤ 1 chain (CD29) and ␣ 4 chain (CD49d), HAP4 cells were negative for CD29 and expressed reduced levels of CD49d (Hedman and Lundgren, 1996) . In contrast to the surface proteins cited above, similar levels of LFA-1 ␣ and ␤ chains were shown to be expressed on the surface of the parental HPB-ALL, HAmut, and HAP4 cell lines. The monoclonal antibody mAb24 was next used due to its specificity toward an epitope exclusively expressed on activated LFA-1 molecules (Dransfield et al., 1992; Landis et al., 1993) . This epitope was found to be present in nearly 50% of HAP4 cells, whereas HPB-ALL and HAmut were not found to express detectable levels of the activated form of LFA-1. This observation confirms previous reports demonstrating variation in the state of LFA-1 activation on the surface of these three different HPB-ALL-derived cell lines as determined by the use of magnetic beads coated with an ICAM-1 fusion protein (Hedman and Lundgren, 1996) .
In agreement with our previous report, we determined that LFA-1 activation is associated with an increased propensity toward HIV-1-mediated syncytium formation and a greater susceptibility to infection with ICAM-1bearing virions. The enhancement of virus-dependent syncytium formation and the higher susceptibility to virus infection seen with HAP4 cells were abrogated by anti-ICAM-1 and anti-LFA-1 antibodies known to block the interaction between LFA-1 and ICAM-1. This information represents direct proof of the importance of the interaction between the activated LFA-1 form and ICAM-1 on the surface of HIU-1 or virally-infected cells. The results obtained with HAP4 cells confirm our previous observations made with the LFA-1-activating NKI-L16 antibody indicating that cells expressing LFA-1 in a conformational state of high affinity for ICAM-1 are much more susceptible to HIV-1-dependent syncytium formation and infection by ICAM-1-bearing viruses (Barbeau et al., 1998; Fortin et al., 1998) . However, unexpectedly, HPB-ALL and HAmut cells were found to be equally susceptible to infection with either ICAM-1/NEG or ICAM-1/POS progeny viruses. These findings are in contrast with previous reports that have shown that HIV-1 particles bearing host-encoded ICAM-1 proteins will more efficiently infect LFA-1-positive cells than virions devoid of host cell membrane ICAM-1 proteins Rizzuto and Sodroski, 1997) . This could be explained by the fact that HPB-ALL cells and its derivatives express very high levels of CD4 (data not shown), much higher than on the surface of cells used in previous studies Rizzuto and Sodroski, 1997) , potentially rendering the ICAM-1-LFA-1 interaction less important when LFA-1 is under a nonactivated state. A recent study has shown that high expression of either the CD4 or the CCR5 molecule could compensate for low expression of CCR5 or CD4, respectively (Platt et al., 1998) . This could suggest that the presence of a strong complementary interaction like LFA-1/ICAM-1 could compensate when low gp120-CD4-coreceptor interactions are occurring.
From a mechanistic point of view, the virus infection event and cell-cell fusion mediated by HIV-1 are quite similar. However, syncytium is more dependent on the density of the viral fusion protein in the cell membrane. Hence, the requirements for syncytium formation are more stringent than those for fusion between the viral membrane and the target cell membrane (Hernandez et al., 1996) . This concept helps to explain that the process of virus entry is apparently independent of ICAM-1-LFA-1 interaction. Several studies have demonstrated the importance of LFA-1 in HIV-1-mediated syncytium formation (Hildreth and Orentas, 1989; Pantaleo et al., 1991) . Interestingly, Gruber et al. (1991) postulated that this ICAM-1-LFA-1 interaction would be crucial only under conditions of minimal viral replication, where the expression of gp120-gp41 on the surface of virus-infected cells would be low. The same authors proposed that cell-cell fusion and syncytium formation should be seen as two different processes. Later, it was suggested that LFA-1 molecules are not necessary for HIV-1 Env-mediated cell membrane fusion but could be required for the slow process of syncytia formation through the stabilization of cell aggregates (Golding et al., 1992) . Those results could suggest that syncytium formation will be favored in aggregated cells, an idea that is supported by our findings with HAP4 cells. This putative dependence of adhesion molecules for viral transmission through syncytium for- FIG. 7 . Linear correlation between the levels of surface CXCR4 expression and susceptibility of studied cells to HIV-1-mediated syncytium formation and virus infection. The numbers of syncytia ( Fig. 3B ) (F) and the extent of virus infection as monitored by measuring virusinduced luciferase activity ( Fig. 5 ) (ᮀ) for each cell lines pretreated with the anti-ICAM-1 RR1/1.1.1 antibody were plotted against the mean fluorescence intensity for surface CXCR4 expression. Linear regression was performed by the least-squares method.
mation is also observed with other retroviruses. For example, others have shown that human T lymphotropic virus type 1-infected cells are able to form syncytia with cells bearing the VCAM-1 molecule (Hildreth et al., 1997) . It can therefore be concluded that this strategy is beneficial for the viral life cycle because this property is shared by different viruses.
The small size of HIV-1 particles and their relatively high surface density of envelope proteins (i.e., gp120) could explain why the process of virus infection is relatively less dependent on complementary interactions such as the one mediated by host-acquired adhesion molecules. However, as demonstrated in this work and previous published studies using ICAM-1-bearing HIV-1 particles, such additional interactions are able to enhance the whole process of virus infection Rizzuto and Sodroski, 1997) . This potentiating effect is seen despite the presence of ideal conditions for the virus infection (i.e., no neutralizing antibodies and high levels of surface viral gp120). In vivo, HIV-1 shows a strong tendency to shed its external envelope proteins (Gelderblom et al., 1987 (Gelderblom et al., , 1985 , and it can be postulated that most of the circulating virions are covered with antibodies, thus reducing the "effective" number of gp120 molecules able to participate to the initial events of infection. In the presence of such "attenuated" virions and given that ICAM-1 molecules are probably found on circulating plasma virions, the importance of the high affinity ICAM-1-LFA-1 interaction is an attractive mode by which viral entities could still be able to efficiently infect target cells under physiological conditions. As stated above for HIV-1-dependent syncytium formation, the ICAM-1-LFA-1 association therefore could help the process of infection under conditions of suboptimal levels of accessible gp120 levels on the virion surface or strongly enhance the efficiency of virus infection under conditions of low stringency. Experiments are in progress to investigate whether the process of infection requires fewer gp120-CD4 interactions for ICAM-1-bearing HIV-1 particles than for progeny viruses devoided of host-derived ICAM-1.
To the best of our knowledge, we provide the first evidence of a positive correlation between cellular susceptibility to HIV-1 infection and the level of surface CXCR4 expression. A similar observation has been previously made for CCR5 because an increase in surface expression of this coreceptor, which is seen during differentiation of monocytes to macrophages, has been associated with an enhanced susceptibility to infection with macrophage-tropic strains of HIV-1 (Tuttle et al., 1998) . Reduced levels of CCR5 on T lymphocytes isolated from individual heterozygotes for the ⌬32 mutation are also associated with a decreased susceptibility to infection by macrophage-tropic HIV-1 isolates (Paxton et al., 1998; Wu et al., 1997) . This newly described correlation between CXCR4 expression and susceptibility for both HIV-1-mediated syncytium formation and virus infection further suggests that a certain degree of similitude exists between these two different virus-dependent processes. The demonstrations that CXCR4 level is lower in the HAP4 cell line and that the variation of CXCR4 level in the different HPB-ALL cell lines is itself affecting HIV-1 infection and virus-mediated syncytium formation in the absence of LFA-1-ICAM-1 interaction suggest that the LFA-1 conformational state can still circumvent conditions of lower coreceptor expression leading under these conditions to higher HIV-1-dependent processes. It would be of interest to define to which extent modifications of the surface levels of CXCR4 could influence susceptibility of cells bearing the activated form of LFA-1 to infection with ICAM-1/POS HIV-1 particles.
Many questions remain to be answered with respect to the putative effect or effects of virally embedded host proteins on the pathogenesis of HIV-1 infection. It is clear that a better understanding of the cellular and viral constituents implicated in fusion of the viral membrane or HIV-1-infected cell membrane with target cell membrane could lead to the development of new therapeutic strategies.
MATERIALS AND METHODS
Cells
The human acute lymphatic leukemia cell line HPB-ALL and its HAmut and HAP4 derivatives have been described previously (Hedman and Lundgren, 1996) . The HAmut cells consist of a mixed population obtained after chemical mutagenesis of the parental HPB-ALL cell line, whereas HAP4 is a clone derived from HAmut after selection for a high ICAM-1-binding phenotype through several rounds of purification using ICAM-1-coated magnetic beads. The J1.1 cell line is a Jurkat E6.1-derivative chronically infected with HIV-1 (Perez et al., 1991) . These cell lines were grown in RPMI 1640 medium supplemented with 10% FCS (Hyclone Laboratories, Logan, UT), glutamine (2 mM), penicillin G (100 U/ml), and streptomycin (100 mg/ml), except for the HAP4 cells, which were grown in RPMI medium with 20% FCS. In our studies, we have also used human embryonic kidney 293T cells (kindly provided by Dr. W. C. Greene) (Pear et al., 1993) . These cells were maintained in DMEM supplemented with 10% FBS, L-glutamine (2 mM), penicillin G (100 U/ml), and streptomycin (100 g/ml).
Plasmids
The proviral plasmid pHXB-Luc was originally derived from pHXB-2D into which a part of the nef gene was deleted and replaced with the luciferase reporter gene (Chen et al., 1994) . This infectious molecular clone of HIV-1 was kindly provided by Dr. D. Baltimore. pCD1.8 is an eukaryotic expression vector containing the entire human ICAM-1 cDNA and was obtained from Dr. T. A. Springer (Staunton et al., 1988) .
Antibodies
The anti-ICAM-1 RR1/1.1.1 monoclonal antibody (anti-CD54) was kindly provided by Dr. Robert Rothlein (Boehringer Ingelheim, Ridgefields, CO) (Rothlein et al., 1986) . Anti-CXCR4 12G5 monoclonal antibody and hybridoma cells secreting the anti-CD4 SIM.4 antibody were supplied by the AIDS Research and Reference Reagent Program (Division of AIDS, NIAID, National Institutes of Health). The mAb24 monoclonal antibody is specific for an LFA-1 activation epitope that maps to the I domain (kindly provided by Dr. N. Hogg) (Landis et al., 1993) . Hybridomas that produce the anti-LFA-1 ␣ chain (anti-CD11a, clone TS1/22.1), anti-LFA-1 ␤ chain (anti-CD18, clone TS1/18.1), and anti-CD4 (clone OKT4) antibodies were obtained from the American Type Culture Collection (Rockville, MD). Antibodies from these producer cell lines were purified with mAbTrap protein G affinity column according to manufacturer's instructions (Pharmacia LKB Biotechnology AB, Uppsala, Sweden).
Production of virus stocks
Isogenic virus particles differing only by the absence or the presence of host-derived ICAM-1 proteins on their outer membranes were produced by calcium phosphate transfection in the 293T cells, as described previously . Cotransfection of pHXB-Luc with pCD1.8 led to the production of virus stocks bearing ICAM-1 molecules on their surfaces (ICAM-1/POS). Transfection of 293T cells with pHXB-Luc only resulted in the production of virus preparations devoid of host-encoded ICAM-1 molecules (ICAM-1/NEG). Virus stocks were normalized for virion content using a commercial assay for the viral major core protein p24 (Organon Teknika, Durham, NC).
Syncytium assay
Uninfected cells and HIV-1-infected cells were dispensed at 2 ϫ 10 6 and 1 ϫ 10 6 cells/ml, respectively, in RPMI supplemented with 20% FCS. Thereafter, 100 l of each cell suspension was added in a 96-well plate in triplicates. Cells were left untreated or treated with RR1/ 1.1.1 (20 g/ml), TS1/22.1 (20 g/ml), or SIM.4 (20 g/ml) before incubation at 37°C. Mixed cells were then allowed to form syncytia for 5-7 h, and syncytia were then counted and photographed with an inverted microscope.
Virus infection
Cells were left untreated or treated for 30 min at 37°C with the anti-LFA-1 TS1/22.1 (20 g/ml) monoclonal antibody. In some experiments, viruses (10 ng of p24) were treated or not treated for 30 min at 37°C with the anti-ICAM-1 RR1/1.1.1 (20 g/ml) before incubation with target cells (10 5 ). Infections were allowed to proceed for 90 min at 37°C. The cells were next washed twice with PBS, resuspended in 200 l of RPMI culture medium, and transferred to a 96-well flat-bottom tissue culture plate (Microtest III; Falcon, Beckton Dickinson, Lincoln Park, NJ). After 72 h of incubation, cells were lysed, and luciferase activity was monitored using a microplate luminometer (MLX; Dynex Technologies, Chantilly, VA) as described previously Fortin et al., 1997) .
